Completed
Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab
NCT02747043
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Research Site Encinitas, California, United States
- Research Site Mount Sterling, Kentucky, United States
- Research Site Billings, Montana, United States
- Research Site Zanesville, Ohio, United States